CSO, Immunologist, PhD in immunology, Adaptive Immune System, ImmunoOncology , autoimmunity and inflammation, Bioengineering, innovator, Scientists, Educator.
South San Francisco, CA
Joined August 2014
- Tweets1.5K
- Following559
- Followers547
- Likes3.4K
Dr. Sawsan Youssef, M.Sc. Ph.D. retweeted
Check out or April issue with a special collection of Reviews & Perspectives on Type 2 Immunity from @RMedzhitov, @LizKopp1 &co, Henrique Veiga-Fernandes & @neuroimmune_rok, Richard Locksley & @Molofsky_lab, Erika Pearce, Edward Pearce, & Agnieszka Kabat cell.com/immunity/issue?pii=…
Dr. Sawsan Youssef, M.Sc. Ph.D. retweeted
RNA therapies market map
124 companies are segmented by approach and highest stage of development
Some takeaways:
Dr. Sawsan Youssef, M.Sc. Ph.D. retweeted
Today we finally published the genomic analyses of hair locks from world-famous music composer Ludwig van #Beethoven. The #genome offers clues to his health and family history! 🧬💇♂️ @CurrentBiology buff.ly/3YZEVY0 (credits: Beethoven-Haus Bonn; T. Begg)
🧵 1/11
Dr. Sawsan Youssef, M.Sc. Ph.D. retweeted
A peritumourally implanted macroporous scaffold releasing small molecules and antibodies to suppress regulatory T cells and to attract and stimulate effector T cells enhanced endogenous antitumoural responses in mice bearing aggressive tumours.
rdcu.be/c2GcL
Dr. Sawsan Youssef, M.Sc. Ph.D. retweeted
The March issue of Science #Immunology is out now!
The cover study shares findings that could help revamp human IgG1 Fc-engineering strategies to enhance future generations of anti-PD-L1 #cancer #immunotherapy drugs: scim.ag/1Mt
Dr. Sawsan Youssef, M.Sc. Ph.D. retweeted
💫DON’T MISS this Review on “Advances in antibody-based therapy in oncology” @NatureCancer by #SaschaZinn #RodrigoVazquezLombardi #CarstenZimmermann #PujaSapra #LutzJermutus and #DanielChrist.
Read it here 👇
nature.com/articles/s43018-0…
rdcu.be/c51Hc
Dr. Sawsan Youssef, M.Sc. Ph.D. retweeted
#Review: Next-generation antigen-presenting cell immune therapeutics for gliomas: buff.ly/3jGbZ8S
by @CatyLeechang & @maciejlesniakmd @NUFeinbergMed in JCI's latest #ReviewSeries: Immune Environment in Glioblastoma: buff.ly/3jW2XVb
Dr. Sawsan Youssef, M.Sc. Ph.D. retweeted
For the last two decades, Lionel Messi and Cristiano Ronaldo have dominated the game of soccer. Here’s how they compare after the World Cup
ti.me/3Wq9nJZ
Dr. Sawsan Youssef, M.Sc. Ph.D. retweeted
Congrats to Argentina and to the GOAT, Lionel Messi, for an amazing World Cup victory.
Dr. Sawsan Youssef, M.Sc. Ph.D. retweeted
Just published @CellCellPress
"Alarming antibody evasion properties of rising #SARSCoV2 BQ and XBB subvariants"
These are the current US variants to reckon with.
Were it not for the immunity wall that's been built, we'd be having a much rougher go at it
cell.com/cell/fulltext/S0092…
Dr. Sawsan Youssef, M.Sc. Ph.D. retweeted
BREAKING: With our partner @BioNTech_Group, we received EUA from the @US_FDA for our Omicron-adapted #COVID19 vaccine in children 6mos-4yrs. Doses to be shipped immediately upon recommendation by CDC. Learn more: on.pfizer.com/3PfrKz4
Dr. Sawsan Youssef, M.Sc. Ph.D. retweeted
Top product forecasts for 2023 go.nature.com/3UpqQAX - a new analysis of the expected top-selling products next year @ByAmyBrown @EvaluatePharma, places the immune checkpoint inhibitor Keytruda at the top
Dr. Sawsan Youssef, M.Sc. Ph.D. retweeted
For readers interested in the history of immune checkpoint inhibitors for cancer therapy, here's a recent perspective go.nature.com/3FhRN53
Dr. Sawsan Youssef, M.Sc. Ph.D. retweeted
Drag-and-drop genome insertion of large sequences without double-strand DNA cleavage using CRISPR-directed integrases bit.ly/3GEisKB
Dr. Sawsan Youssef, M.Sc. Ph.D. retweeted
Boieri, @CaImmunoprevent et al. demonstrate that CD4+ T helper cells directly block #breastcancer development by forcing the cancer cells to terminally differentiate. bit.ly/3NQTnMH
From our #Cancer #Immunotherapy collection: bit.ly/3UB7vxh
#SITC22
Dr. Sawsan Youssef, M.Sc. Ph.D. retweeted
Those readers attending the Resistance to Checkpoint Blockade Immunotherapy session at #SITC22 this morning, might find this article by Lieping Chen of interest go.nature.com/3G5KWwG
Dr. Sawsan Youssef, M.Sc. Ph.D. retweeted
📢 There's a new #review in @sigtrans_sttt!
It describes the efforts to manipulate the immune system against #cancer, and different targets and cell types that can be exploited to promote the antitumor immune response.
📌 Read it here: go.nature.com/3xGcQKs
Dr. Sawsan Youssef, M.Sc. Ph.D. retweeted
+++ Omicron BA.4/BA.5 vaccine update +++ The FDA today granted Emergency Use Authorization (EUA) of a 30-µg booster dose of our Omicron BA.4/BA.5 bivalent vaccine, as a booster for individuals ages 12 years and older. investors.biontech.de/news-r…
